22157.jpg
ITI-1000 (pp65 DC vaccine) for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan
January 24, 2024 09:09 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ITI-1000 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Roots-Analysis-Logo.png
The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis
March 24, 2022 13:19 ET | Roots Analysis
London, March 24, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings. With 13 drugs approved in the...
Roots-Analysis-Logo.png
The immunocytokines market is estimated to be worth around USD 5.4 billion by 2030, claims Roots Analysis
June 30, 2021 10:55 ET | Roots Analysis
London, June 30, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Immunocytokines Market, 2021-2030” report to its list of offerings. These engineered...